Tag:
clinical tri
Latest Headlines
Latest Headlines
Sanofi touts two-year results of MS drug teriflunomide
Just one day after Genzyme announced signs of remission in five-year data of its MS drug alemtuzumab, Sanofi-Aventis said two-year data from its study of teriflunomide showed that the drug
